Dongguan City Xinyuan Nonwoven sold three medical face masks in the U.S. without FDA clearance and with misleading FDA-certification claims.
What happened
FDA reviewed the company's website on May 19, 2021, and its Alibaba storefront on May 12, 2021. FDA found the firm offering three medical face masks for sale in the U.S. without marketing approval, clearance, or authorization, and using claims and certificates that implied FDA approval.
What FDA found
The firm offered medical face masks for sale in the U.S. without FDA premarket approval or an approved investigational device exemption, making them adulterated.
section 501(f)(1)(B), 21 U.S.C. § 351(f)(1)(B); section 515(a), 21 U.S.C. § 360e(a); section 520(g), 21 U.S.C. § 360j(g)The firm did not notify FDA of its intent to commercially distribute the devices as required by section 510(k), making them misbranded.
section 502(o), 21 U.S.C. § 352(o); section 510(k), 21 U.S.C. § 360(k)The product labeling included a false or misleading reference to 'CE FDA dual certification.'
section 502(a), 21 U.S.C. § 352(a)The firm displayed third-party registration certificates with the FDA logo and eagle that implied FDA approval or endorsement of the company or device.
21 CFR 807.39; section 502(a), 21 U.S.C. § 352(a)
What FDA wants
FDA asks the firm to notify it in writing within 15 business days of the specific steps taken to correct the violations and prevent recurrence, including documentation and a timetable for any planned actions.
Who should pay attention
- buyers sourcing medical masks from overseas suppliers
- distributors and importers of medical devices
- companies relying on third-party FDA registration certificates
This is a summary. Read the original letter on fda.gov.